Observational studyScientific reports2025
GC-MS/MS analysis of seminal plasma PUFAs in distinct subgroups of infertile men: diagnostic potential and insight into mechanisms of male infertility.
Observational study in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Association between GLM7 glycolipid metabolism index and female infertility: A cross-sectional analysis of NHANES 2013-2020.Medicine · 2026Article
- Article
- Article
- Biomarkers and Mechanisms of Male Infertility: Evaluation of Antioxidant Enzymes and Arachidonic Acid Derivatives in Seminal Plasma from Fertile and Infertile Men.Antioxidants (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Infertility affects approximately 17.5% of the adult population, with the male factor contributing to nearly half of the cases. Seminal plasma has emerged as a potential source of biomarkers and insights into the mechanisms of male infertility; however, the significance of polyunsaturated fatty acids (PUFAs) in this body fluid remains insufficiently explored. The main objectives of the present observational study were to compare selected PUFA (linoleic acid (LA), α-linolenic acid (ALA), γ-linolenic acid (GLA), arachidonic acid (AA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA)) concentrations and ratios in seminal plasma between fertile (n = 22, aged 21-47) and infertile (n = 250, aged 24-45) men, as well as within infertile subgroups, including idiopathic, to investigate their clinical utility and correlations with semen parameters. An optimized extraction procedure and a validated gas chromatography-tandem mass spectrometry (GC-MS/MS) method were employed to determine the concentrations of PUFAs in seminal plasma. Nonparametric tests, including Mann-Whitney U test, ANOVA rank test followed by Tukey's post hoc test, Spearman's rank test, and ROC curves were used for analyses. Among the twenty-one examined parameters, nine (LA, GLA, EPA, DHA, ALA/LA, LA/AA, EPA/ALA, EPA/GLA, EPA/AA) exhibited significant differences between fertile control group and infertile patients (0.493 vs. 0.762 μg/mL, p = 0.007; 0.029 vs. 0.035 μg/mL, p = 0.005; 0.007 vs. 0.009 μg/mL, p < 0.001; 1.519 vs. 2.174 μg/mL, p = 0.029; 0.066 vs. 0.053, p = 0.042; 0.248 vs. 0.305, p = 0.002; 0.168 vs. 0.216, p = 0.010; 0.230 vs. 0.283, p = 0.013; 0.003 vs. 0.004 p = 0.045, respectively), with LA, GLA, LA/AA, EPA/ALA, and EPA/GLA demonstrating limited (AUC < 0.650), and EPA exhibiting moderate diagnostic value (AUC = 0.709). Among the subgroups of infertile patients, the teratozoospermic group displayed the most pronounced alterations in both individual PUFA concentrations and PUFA ratios compared to other groups (p < 0.05). Notably, DHA, LA/DHA, ALA/DHA, GLA/DHA, AA/DHA, EPA/DHA exhibited at least one moderate correlation with semen parameters (0.4 <|R|, p < 0.05). Despite its exploratory nature, the present study provides insights into the mechanisms underlying male infertility and their reflection in seminal plasma composition while simultaneously outlining new directions in identifying/excluding PUFA concentrations or ratios (especially LA, GLA, EPA, DHA, ALA/LA, LA/AA, EPA/ALA, EPA/GLA, EPA/AA) as potential biomarkers. Moreover, the use of GC-MS/MS method offers a novel approach for potential future diagnostic applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.